Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia.

Bone Marrow Transplant · 2011 · PMC3203202 · PMID 21151180

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp=0.06so close (0.05 < p ≤ 0.1)

A proportional-hazards model regression analysis was performed to look at 2 nd -dose busulfan AUC as a continuous-variable predictor of relapse with non-relapse death as a competing risk; AUC was borderline significant at p=0.06.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.